Abstract
Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a newly developed hydroxy radical scavaging agent which has been widely used for protection against ischemia-reperfusion injury is highly effective in preventing cell apoptosis. However, the exact intracellular mechanism(s) underlying the protective action of edaravone is not clear. We observed that in PC12 cells cultured under serum deprivation (DEPV) condition, the levels of survivin were positively correlated with the anti-apoptotic action of edaravone. Survivin RNA interference (RNAi) increased DEPV-induced PC12 cell apoptosis, whereas the anti-apoptotic effect of edaravone was blunted by survivin RNAi. Moreover, survivin overexpression provided protection against DEPV-induced PC12 cell apoptosis. Inhibition of ERK and PI3-K/AKT prevented edaravone’s ability to decrease apoptosis and increase survivin. In conclusion, the present study provides the first direct evidence that survivin involves in the anti-apoptotic effects of edaravone via a pathway involving ERK and PI3-K/AKT.
Similar content being viewed by others
References
Tabrizchi R (2000) Edaravone Mitsubishi-Tokyo. Curr Opin Investig Drugs 1:347–354
Yoshida H, Yanai H, Namiki Y et al (2006) Neuroprotective effects of edaravone: a novel free radical scavenger in cerebrovascular injury. CNS Drug Rev 12:9–20. doi:10.1111/j.1527-3458.2006.00009.x
Song Y, Li M, Li JC et al (2006) Edaravone protects PC12 cells from ischemic-like injury via attenuating the damage to mitochondria. J Zhejiang Univ Sci B 7:749–756. doi:10.1631/jzus.2006.B0749
Amemiya S, Kamiya T, Nito C et al (2005) Anti-apoptotic and neuroprotective effects of edaravone following transient focal ischemia in rats. Eur J Pharmacol 516:125–130. doi:10.1016/j.ejphar.2005.04.036
Ambrosini G, Adida C, Altieri DC (1997) A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3:917–921. doi:10.1038/nm0897-917
Altieri DC (2003) Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene 22:8581–8589. doi:10.1038/sj.onc.1207113
Du C, Fang M, Li Y et al (2000) Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102:33–42. doi:10.1016/S0092-8674(00)00008-8
Jiang Y, de Bruin A, Caldas H et al (2005) Essential role for survivin in early brain development. J Neurosci 25:6962–6970. doi:10.1523/JNEUROSCI.1446-05.2005
Zhang Y, Zhu W, Wang YG et al (2006) Interaction of SH2-Bbeta with RET is involved in signaling of GDNF-induced neurite outgrowth. J Cell Sci 119:1666–1676. doi:10.1242/jcs.02845
Yao LL, Wang YG, Cai WJ et al (2007) Survivin mediates the anti-apoptotic effect of delta-opioid receptor stimulation in cardiomyocytes. J Cell Sci 120:895–907. doi:10.1242/jcs.03393
Houkin K, Nakayama N, Kamada K et al (1998) Neuroprotective effect of the free radical scavenger MCI-186 in patients with cerebral infarction: clinical evaluation using magnetic resonance imaging and spectroscopy. J Stroke Cerebrovasc Dis 7:315–322. doi:10.1016/S1052-3057(98)80049-9
Xiao B, Bi FF, Hu YQ et al (2007) Edaravone neuroprotection effected by suppressing the gene expression of the Fas signal pathway following transient focal ischemia in rats. Neurotox Res 12:155–162
Watanabe K, Ma M, Wen J et al (2007) Effects of edaravone in heart of aged rats after cerebral ischemia-reperfusion injury. Biol Pharm Bull 30:460–464. doi:10.1248/bpb.30.460
Asai T, Ohno Y, Minatoguchi S et al (2007) The specific free radical scavenger edaravone suppresses bleomycin-induced acute pulmonary injury in rabbits. Clin Exp Pharmacol Physiol 34:22–26. doi:10.1111/j.1440-1681.2007.04528.x
Tsujimoto I, Hikoso S, Yamaguchi O et al (2005) The antioxidant edaravone attenuates pressure overload-induced left ventricular hypertrophy. Hypertension 45:921–926. doi:10.1161/01.HYP.0000163461.71943.e9
Sasano N, Enomoto A, Hosoi Y et al (2007) Free radical scavenger edaravone suppresses x-ray-induced apoptosis through p53 inhibition in MOLT-4 cells. J Radiat Res (Tokyo). 48:495–503
Kawasaki T, Kitao T, Nakagawa K et al (2007) Nitric oxide-induced apoptosis in cultured rat astrocytes: protection by edaravone, a radical scavenger. Glia 55:1325–1333. doi:10.1002/glia.20541
Wu T, Ding XS, Wang W et al (2006) MCI-186 (3-methyl-1-phenyl-2-pyrazolin-5-one) attenuated simulated ischemia/reperfusion injury in cultured rat hippocampal cells. Biol Pharm Bull 29:1613–1617. doi:10.1248/bpb.29.1613
Tischler AS, Lee YC, Slayton VW et al (1982) Content and release of neurotensin in PC12 pheochromocytoma cell cultures: modulation by dexamethasone and nerve growth factor. Regul Pept 3:415–421. doi:10.1016/0167-0115(82)90064-7
Gotz R, Karch C, Digby MR et al (2000) The neuronal apoptosis inhibitory protein suppresses neuronal differentiation and apoptosis in PC12 cells. Hum Mol Genet 9:2479–2489. doi:10.1093/hmg/9.17.2479
Asanuma H, Torigoe T, Kamiguchi K et al (2005) Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer cells. Cancer Res 65:11018–11025. doi:10.1158/0008-5472.CAN-05-0491
Acknowledgments
This study was supported by grants from the Foundation of Science and Technology Commission of Shanghai Municipality (04ZR14021) and the Foundation of Excellent Youth Scientist of Tongji University.
Author information
Authors and Affiliations
Corresponding author
Additional information
Xue-Yuan Liu and Ling-Ling Yao have contributed equally to this study.
Rights and permissions
About this article
Cite this article
Liu, XY., Yao, LL., Chen, YJ. et al. Survivin is involved in the anti-apoptotic effect of edaravone in PC12 cells. Mol Cell Biochem 327, 21–28 (2009). https://doi.org/10.1007/s11010-009-0037-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-009-0037-1